KBRA Releases Research – Synthetic Risk Transfers Taking the Spotlight
NEW YORK--(BUSINESS WIRE)-- KBRA releases research that examines synthetic risk transfer (SRT) transactions. Dialogue with market participants regarding SRTs has increased ahead of upcoming Basel 3 regulations set to take effect in mid-2025.
The regulations will substantially change how risk-weighted assets are calculated, resulting in rising capital charges for various portfolio assets. The combination of higher expected regulatory risk weightings and substantial legacy portfolio holdings with unfavorable prospects for sale—since the assets are priced below prevailing higher interest rates—is expected to further encourage risk transfer efforts.
KBRA’s approach to SRTs involves the utilization of asset-specific methodologies applicable to cash securitizations, with consideration given to transaction structures that continue to evolve. KBRA will evaluate features that provide additional credit support as well as key counterparties, in determining whether credit-linked notes are not constrained by the credit quality of the issuer.
KBRA has rated several SRT transactions, with market conditions suggesting a significant pickup in the use of these structures going forward. The report includes a list of KBRA-rated transactions.
Click here to view the report.
About KBRA
KBRA is a full-service credit rating agency registered in the U.S., the EU, and the UK, and is designated to provide structured finance ratings in Canada. KBRA’s ratings can be used by investors for regulatory capital purposes in multiple jurisdictions.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240220114668/en/
Contacts
Sharif Mahdavian, RMBS
+1 646-731-2301
[email protected]
Killian Walsh, European Structured Finance
+353 1 588 1184
[email protected]
Jack Kahan, Head of Global RMBS
+1 646-731-2486
[email protected]
Eric Neglia, Head of Commercial and Consumer ABS
+1 646-731-2456
[email protected]
John Hogan, Global Head of Ratings Legal
+44 20 8148 1040
[email protected]
Business Development Contacts
Rosemary Kelley, Senior Managing Director
+1 646-731-2337
[email protected]
Mauricio Noé, Co-Head of Europe
+44 20 8148 1010
[email protected]
Source: KBRA
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morse Micro Selects Pace Wireless for its Wi-Fi HaLow Design Partner Program
- Genetix Biotherapeutics and the National Football League Alumni Association Announce Partnership to Increase Awareness for Sickle Cell Disease and Transformative Treatment Options
- FDA Seeks Public Feedback to Inform Regulatory Approach for Generative AI-Enabled Medical Devices
Create E-mail Alert Related Categories
Business Wire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share